Stock Analysis

Fewer Investors Than Expected Jumping On Fujian Tianma Science and Technology Group Co., Ltd (SHSE:603668)

SHSE:603668
Source: Shutterstock

When close to half the companies operating in the Food industry in China have price-to-sales ratios (or "P/S") above 1.5x, you may consider Fujian Tianma Science and Technology Group Co., Ltd (SHSE:603668) as an attractive investment with its 1x P/S ratio. Although, it's not wise to just take the P/S at face value as there may be an explanation why it's limited.

Check out our latest analysis for Fujian Tianma Science and Technology Group

ps-multiple-vs-industry
SHSE:603668 Price to Sales Ratio vs Industry September 30th 2024

How Fujian Tianma Science and Technology Group Has Been Performing

As an illustration, revenue has deteriorated at Fujian Tianma Science and Technology Group over the last year, which is not ideal at all. It might be that many expect the disappointing revenue performance to continue or accelerate, which has repressed the P/S. Those who are bullish on Fujian Tianma Science and Technology Group will be hoping that this isn't the case so that they can pick up the stock at a lower valuation.

Want the full picture on earnings, revenue and cash flow for the company? Then our free report on Fujian Tianma Science and Technology Group will help you shine a light on its historical performance.

Is There Any Revenue Growth Forecasted For Fujian Tianma Science and Technology Group?

Fujian Tianma Science and Technology Group's P/S ratio would be typical for a company that's only expected to deliver limited growth, and importantly, perform worse than the industry.

Retrospectively, the last year delivered a frustrating 5.2% decrease to the company's top line. Even so, admirably revenue has lifted 54% in aggregate from three years ago, notwithstanding the last 12 months. Accordingly, while they would have preferred to keep the run going, shareholders would definitely welcome the medium-term rates of revenue growth.

Comparing that to the industry, which is predicted to deliver 16% growth in the next 12 months, the company's momentum is pretty similar based on recent medium-term annualised revenue results.

In light of this, it's peculiar that Fujian Tianma Science and Technology Group's P/S sits below the majority of other companies. It may be that most investors are not convinced the company can maintain recent growth rates.

What We Can Learn From Fujian Tianma Science and Technology Group's P/S?

Using the price-to-sales ratio alone to determine if you should sell your stock isn't sensible, however it can be a practical guide to the company's future prospects.

The fact that Fujian Tianma Science and Technology Group currently trades at a low P/S relative to the industry is unexpected considering its recent three-year growth is in line with the wider industry forecast. When we see industry-like revenue growth but a lower than expected P/S, we assume potential risks are what might be placing downward pressure on the share price. It appears some are indeed anticipating revenue instability, because the persistence of these recent medium-term conditions should normally provide more support to the share price.

You need to take note of risks, for example - Fujian Tianma Science and Technology Group has 3 warning signs (and 2 which are potentially serious) we think you should know about.

If strong companies turning a profit tickle your fancy, then you'll want to check out this free list of interesting companies that trade on a low P/E (but have proven they can grow earnings).

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

‱ Dividend Powerhouses (3%+ Yield)
‱ Undervalued Small Caps with Insider Buying
‱ High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.